Vernex™wound healing device containing a small amount of salmon roe extract. Salmon roe extract have shown a series of pre-clinical effect on ex vivo skin and skin cells that could be beneficial for wound healing.

The Vernex® device is a complete device in a "bag on valve" concept that will be produced by Paragon Nordic AS (Swe). Paragon Nordic AS is certified by the Swedish Medicinal Product Agency for drug production. 

The final device contains  salmon roe extract, sterilized  at pH 7.4. Salmon roe extract, is presumed to improve the environment in which re-epithelialization of a wound surface takes place.  This is supported by the findings in an ex-vivo human explant skin study of secondary degree burns, where the salmon roe extract is shown to increase re-epithelialization of wound surfaces compared to control. 


Regenics AS have developed clinical proof of efficacy and safety  in human 2 degree burn wounds for our products Collex® and Vernex®.

The procudts are beeing developed as class III devices. WoundClear® is developed as a BLA/EU CP biotech drug.